ClinicalTrials.govpublic full text
Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)
node; prostate, bone metastases, prostate cancer patients, sbrt (stereotactic body radiation therapy), durvalumab, tep-fch, tep-psma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849127
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.